Sun Pharmaceutical Industries: Innovative Medicines and India Key Drivers. Maintain BUY
We recently interacted with the senior management of Sun Pharma—Ms. Jayashree Satagopan, CFO, and Dr. Abhishek Sharma, Head IR.
498 Views
Sun Pharmaceutical Industries: Halol Observations Were Critical, No Relief to Plant.
Sun Pharma’s (SUNP) formulation manufacturing facility at Halol (Gujarat, India) had an inspection from the USFDA for current Good Manufacturing...
542 Views
Sun Pharmaceutical Industries: Checkpoint Acquisition to Strengthen Specialty Business.
Sun Pharma (SUNP) and Checkpoint Therapeutics Inc (Checkpoint) have entered into an agreement under which SUNP will acquire Checkpoint, an...
305 Views
Sun Pharmaceutical Industries: Checkpoint Acquisition to Strengthen Specialty Business
Sun Pharma (SUNP) and Checkpoint Therapeutics Inc (Checkpoint) have entered into an agreement under which SUNP will acquire Checkpoint, an...
309 Views
Sun Pharmaceutical Industries: Specialty and Domestic Formulation to Drive Growth.
Sun Pharma (SUNP) is expected to sustain steady growth momentum, driven by strong traction in its global specialty business (18% of sales)
481 Views